Heterologous protection against influenza by injection of DNA encoding a viral protein
- PMID: 8456302
- DOI: 10.1126/science.8456302
Heterologous protection against influenza by injection of DNA encoding a viral protein
Abstract
Cytotoxic T lymphocytes (CTLs) specific for conserved viral antigens can respond to different strains of virus, in contrast to antibodies, which are generally strain-specific. The generation of such CTLs in vivo usually requires endogenous expression of the antigen, as occurs in the case of virus infection. To generate a viral antigen for presentation to the immune system without the limitations of direct peptide delivery or viral vectors, plasmid DNA encoding influenza A nucleoprotein was injected into the quadriceps of BALB/c mice. This resulted in the generation of nucleoprotein-specific CTLs and protection from a subsequent challenge with a heterologous strain of influenza A virus, as measured by decreased viral lung titers, inhibition of mass loss, and increased survival.
Comment in
-
Naked DNA points way to vaccines.Science. 1993 Mar 19;259(5102):1691-2. doi: 10.1126/science.8456293. Science. 1993. PMID: 8456293 No abstract available.
Similar articles
-
Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.J Virol. 1994 Jun;68(6):3505-11. doi: 10.1128/JVI.68.6.3505-3511.1994. J Virol. 1994. PMID: 7514677 Free PMC article.
-
Naked DNA points way to vaccines.Science. 1993 Mar 19;259(5102):1691-2. doi: 10.1126/science.8456293. Science. 1993. PMID: 8456293 No abstract available.
-
Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.J Immunol. 1999 Apr 1;162(7):4163-70. J Immunol. 1999. PMID: 10201942
-
Protective efficacy of intramuscular immunization with naked DNA.Ann N Y Acad Sci. 1995 Nov 27;772:40-6. doi: 10.1111/j.1749-6632.1995.tb44730.x. Ann N Y Acad Sci. 1995. PMID: 8546412 Review. No abstract available.
-
Cytotoxic T cells in influenza infection.Ann N Y Acad Sci. 1988;532:230-7. doi: 10.1111/j.1749-6632.1988.tb36342.x. Ann N Y Acad Sci. 1988. PMID: 2845845 Review. No abstract available.
Cited by
-
Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.J Control Release. 2013 Dec 10;172(2):579-88. doi: 10.1016/j.jconrel.2013.04.016. Epub 2013 Apr 30. J Control Release. 2013. PMID: 23643528 Free PMC article.
-
Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.Virol J. 2012 Jun 27;9:127. doi: 10.1186/1743-422X-9-127. Virol J. 2012. PMID: 22738661 Free PMC article.
-
The Limitless Future of RNA Therapeutics.Front Bioeng Biotechnol. 2021 Mar 18;9:628137. doi: 10.3389/fbioe.2021.628137. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 33816449 Free PMC article. Review.
-
Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles.J Control Release. 2012 Oct 28;163(2):230-9. doi: 10.1016/j.jconrel.2012.08.011. Epub 2012 Aug 19. J Control Release. 2012. PMID: 22921518 Free PMC article.
-
DNA vaccines: developing new strategies against cancer.J Biomed Biotechnol. 2010;2010:174378. doi: 10.1155/2010/174378. Epub 2010 Mar 28. J Biomed Biotechnol. 2010. PMID: 20368780 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources